semaglutide shortage november 2025 news compounding Drug compounders sue FDA over declaration ending Wegovy Novo Nordisk further lowers prices – Despite FDA ruling, compounded GLP-1s

News Updates For The Ozempic Litigation July 1, 2026: GLP-1 MDL Grows as More Patients Claim They Were Not Told About Side Effects of Ozempic, Other Drugs 85 more lawsuits have joined the MDL against companies that made Ozempic and other GLP-1 drugs

In-vitro studies explore how this anti-aging peptide interacts with fibroblasts to modulate these components

Of note, all AEs outcomes for pancreatic carcinoma metastatic ( n = 12) were severe, while all oropharyngeal discomfort ( n = 11) were non-severe

Extensive monitoring

Each peptide targets different but complementary mechanisms, with KPV adding potent anti-inflammatory activity through NF-B inhibition